Research supported by the National Institutes of Health (NIH) spurs medical innovation and discoveries around the world. The United States has long been the global leader in medical research, but stagnant funding threatens America’s position as other countries increase their investments.
Adjusted for inflation, NIH receives nearly 19 percent less funding today than it did in 2003. If current trends continue, China will outspend the U.S. on research and development by the year 2022. We cannot afford to let America fall behind. American competitiveness depends on U.S. leadership as the largest funder of biomedical research in the world.
It is critical that NIH receives the funding needed to support outstanding scientists who will spark the next generation of scientific breakthroughs and maintain America’s role as the leader in medical innovation.
For more information, please download the full fact sheet here.
what's at stake?
Stagnant funding for the National Institutes of Health (NIH) means stalled progress in the fight against costly and devastating diseases, lost economic output, and the forfeiting of America’s global leadership in research and development. We need to make the NIH research budget whole again.
Investing in our health.
Creating jobs, spurring growth.
Protecting our citizens.
Ensuring U.S. competitiveness.